R
Revolo Biotherapeutics
Developing revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases
About Revolo Biotherapeutics
Revolo Biotherapeutics is a pioneering biotherapeutics company focused on transforming the treatment landscape for autoimmune and allergic diseases. The company develops innovative therapies designed to reset the immune system, aiming for long-term disease remission after just a single administration. Revolo Biotherapeutics serves patients suffering from various autoimmune and allergic conditions, operating within the biopharmaceutical market. The company's business model revolves around drug discovery and development, leveraging its unique disease-agnostic approach to create groundbreaking treatments. Revenue is generated through the development and commercialization of these therapies, as well as potential partnerships and licensing agreements. With headquarters in Gaithersburg, MD, USA, and London, UK, Revolo Biotherapeutics has a global footprint and is led by a team of seasoned experts in immunology and biopharmaceuticals.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2020 | $54M | $214M | Morningside · Metellus · 24Haymarket | — |
| SERIES AOther financing | Nov 2018 | $0 | — | 24Haymarket · NCL Technology Ventures | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Revolo Biotherapeutics is 180 monthly website visits, up 125% over the last three months. Revolo Biotherapeutics's team declined 5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Revolo Biotherapeutics in the Gaithersburg ecosystem
The Revolo Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
NCL Technology Ventures
Series A3 investors entered at this stage
24Haymarket
Morningside
Metellus
Other known investors1 additional known investor
Oregon Health & Science University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Revolo Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Revolo Biotherapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









